Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Language
Publication year range
1.
Br J Radiol ; 85(1014): 800-6, 2012 Jun.
Article in English | MEDLINE | ID: mdl-22665926

ABSTRACT

OBJECTIVE: Unenhanced helical CT for kidney, ureter and bladder (CT KUB) has become the standard investigation for renal colic. This study aims to determine the sensitivity of scout radiographs in detecting ureteric calculi using CT KUB as a standard reference. METHODS: A retrospective review of consecutive patients who presented with acute flank pain and were investigated using CT KUB. 201 patients with positive ureteric calculi were included. Two radiologists independently reviewed the scout radiographs with access to CT KUB images. Each observer recorded the presence or absence of calculi, location, size and mean Hounsfield units of each calculus. RESULTS: 203 ureteric calculi were analysed from 201 patients. The overall sensitivity of scout radiographs for Observer A was 42.3% and for Observer B 52.2%, with an interobserver reliability κ-value of 0.78. The significance of mean Hounsfield units and size between two groups of patients with visible stones and those not visible were tested; the p-value for both variables was <0.0001, which is statistically significant. The study found that calculi in the upper ureter and larger than 4 mm are more likely to be seen on the scout radiograph. CONCLUSIONS: Usage of CT scout radiography should be encouraged and reported routinely in conjunction with CT KUB as a baseline for treatment follow-up.


Subject(s)
Tomography, Spiral Computed , Ureteral Calculi/diagnostic imaging , Adolescent , Adult , Aged , Aged, 80 and over , Female , Hospitals , Humans , Male , Middle Aged , Referral and Consultation , Retrospective Studies , Sensitivity and Specificity , United Kingdom , Young Adult
3.
Perfusion ; 22(1): 57-61, 2007 Jan.
Article in English | MEDLINE | ID: mdl-17633136

ABSTRACT

Perioperative volume replacement after cardiopulmonary bypass is complicated by post-bypass systemic inflammatory process. The aim of this study was to assess the effects of using two different colloid solutions as priming fluids in cardiopulmonary bypass. The study's primary end point was to measure the amount of fluid replacement needed during and post-cardiopulmonary bypass; blood loss, change in blood profile and intraocular pressure were secondary end points, used as measures of plasma oncotic pressures. Patients undergoing coronary artery bypass grafting were recruited. Both patients and surgeons were blinded to receive either Gelofusine or Voluven as priming fluids. At fixed intervals during cardiopulmonary bypass, the patients had their intraocular pressures measured. Intra and postoperative fluid replacement was in the form of 4.5% human albumin and the amount was recorded for each subject. The result did not show any significant differences in the amount of fluid needed to be replaced, in blood loss or in blood profile between the two groups. However, it showed an increase in intraocular pressure in both groups once cardiopulmonary bypass commenced. The average intraocular pressure was higher in the Gelofusine group compared to the Voluven group. The significant increase in intraocular pressure measurements in the Gelofusine group compared to the Voluven group support the hypothesis that Voluven maintains the plasma oncotic pressure better and reduces fluid shift.


Subject(s)
Cardiopulmonary Bypass/methods , Gelatin/therapeutic use , Plasma Substitutes/therapeutic use , Starch/therapeutic use , Aged , Blood Loss, Surgical/prevention & control , Colloids , Double-Blind Method , Female , Gelatin/pharmacology , Humans , Hydroxyethyl Starch Derivatives/pharmacology , Hydroxyethyl Starch Derivatives/therapeutic use , Intraocular Pressure/drug effects , Male , Middle Aged , Plasma Substitutes/pharmacology , Polygeline/pharmacology , Polygeline/therapeutic use , Starch/pharmacology
4.
Heart ; 91(6): e49, 2005 Jun.
Article in English | MEDLINE | ID: mdl-15894750

ABSTRACT

Primary cardiac tumours are discovered in about 1 in 2000 necropsies. Cardiac myxomas make up half of all benign intracardiac tumours. Seventy five per cent are located in the left atrium. The first left atrial myxoma arising from the left atrium of a transplanted heart is reported.


Subject(s)
Heart Neoplasms/diagnostic imaging , Heart Transplantation , Myxoma/ultrastructure , Aged , Cardiomyopathy, Hypertrophic/surgery , Heart Atria , Heart Failure/surgery , Heart Neoplasms/pathology , Heart Neoplasms/surgery , Humans , Immunosuppressive Agents/therapeutic use , Male , Myxoma/pathology , Myxoma/surgery , Second-Look Surgery , Ultrasonography
5.
Cancer ; 91(4): 779-84, 2001 Feb 15.
Article in English | MEDLINE | ID: mdl-11241246

ABSTRACT

BACKGROUND: Primary pulmonary osteosarcoma is an extremely rare malignancy. To date, only 12 cases have been reported, with a high mortality rate. The authors report on a newly diagnosed patient and describe investigations that were performed using immunohistochemistry and comparative genomic hybridization (CGH). METHODS: The clinical course of a woman age 37 years is presented. Along with routine histologic examination, immunohistochemistry was used to demonstrate differentiation-associated proteins, oncoproteins, and other markers; CGH analysis for genomic alterations; and histochemistry to demonstrate alkaline phosphatase activity. RESULTS: Immunohistochemical analysis showed varying expression patterns using antibodies against a panel of tumor markers. Most notable was high overexpression of BCL-2 and cyclin D. CGH analysis showed that this neoplasm contained a much higher level of genetic aberrations compared with skeletal osteosarcoma. CONCLUSIONS: This tumor exhibited features common to skeletal osteosarcomas but also had some unique features. Genome analysis suggests that this tumor has several genetic aberrations in common with extraskeletal osteosarcoma. The novel regions of instability identified within the tumor genome may contribute toward the unique tumor phenotype and relative chemoresistance.


Subject(s)
Bone Neoplasms/secondary , Lung Neoplasms/genetics , Lung Neoplasms/pathology , Osteosarcoma/genetics , Osteosarcoma/pathology , Adult , Biomarkers , Chromosome Aberrations , Combined Modality Therapy , Cyclin D1/metabolism , Female , Humans , Immunohistochemistry , Lung Neoplasms/metabolism , Lung Neoplasms/therapy , Nucleic Acid Hybridization , Osteosarcoma/metabolism , Osteosarcoma/therapy , Phenotype , Proto-Oncogene Proteins c-bcl-2/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL